GJIC
GSK icon

Gamble Jones Investment Counsel’s GSK GSK Stock Holding History

Gamble Jones Investment Counsel’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$376K Hold
10,693
– – 0.03% 159
2022
Q3 		$315K Sell
10,693
-1
-0% -$38 0.03% 165
2022
Q2 		$582K Hold
10,694
– – 0.04% 143
2022
Q1 		$582K Buy
10,694
+2,120
+25% +$115K 0.04% 150
2021
Q4 		$473K Buy
8,574
+80
+0.9% +$4.16K 0.03% 162
2021
Q3 		$406K Sell
8,494
-320
-4% -$16.1K 0.03% 164
2021
Q2 		$439K Buy
8,814
+120
+1% +$5.77K 0.03% 164
2021
Q1 		$388K Sell
8,694
-1,463
-14% -$66.4K 0.03% 171
2020
Q4 		$467K Hold
10,157
– – 0.03% 156
2020
Q3 		$478K Sell
10,157
-1
-0% -$50 0.03% 150
2020
Q2 		$518K Hold
10,158
– – 0.04% 143
2020
Q1 		$481K Sell
10,158
-311
-3% -$16.6K 0.04% 143
2019
Q4 		$615K Sell
10,469
-2,185
-17% -$122K 0.05% 150
2019
Q3 		$675K Buy
12,654
+8
+0.1% +$412 0.06% 141
2019
Q2 		$633K Sell
12,646
-569
-4% -$28.6K 0.05% 148
2019
Q1 		$690K Buy
13,215
+89
+0.7% +$4.45K 0.06% 138
2018
Q4 		$627K Sell
13,126
-2,073
-14% -$102K 0.06% 139
2018
Q3 		$763K Sell
15,199
-238
-2% -$12.1K 0.07% 136
2018
Q2 		$778K Sell
15,437
-693
-4% -$34.9K 0.08% 133
2018
Q1 		$788K Sell
16,130
-84
-0.5% -$3.91K 0.08% 133
2017
Q4 		$719K Sell
16,214
-53
-0.3% -$2.45K 0.07% 139
2017
Q3 		$826K Sell
16,267
-4,093
-20% -$208K 0.08% 132
2017
Q2 		$1.1M Buy
20,360
+510
+3% +$27.2K 0.11% 118
2017
Q1 		$1.05M Sell
19,850
-1,168
-6% -$59.3K 0.11% 119
2016
Q4 		$1.01M Buy
21,018
+464
+2% +$22.9K 0.11% 121
2016
Q3 		$1.11M Buy
20,554
+192
+0.9% +$10.5K 0.12% 113
2016
Q2 		$1.1M Sell
20,362
-620
-3% -$32.7K 0.12% 117
2016
Q1 		$1.06M Sell
20,982
-660
-3% -$32.9K 0.12% 114
2015
Q4 		$1.09M Sell
21,642
-1,542
-7% -$78.6K 0.12% 111
2015
Q3 		$1.11M Sell
23,184
-6,423
-22% -$334K 0.13% 109
2015
Q2 		$1.54M Buy
29,607
+706
+2% +$39.8K 0.16% 103
2015
Q1 		$1.67M Sell
28,901
-1,339
-4% -$76.8K 0.17% 97
2014
Q4 		$1.62M Buy
30,240
+805
+3% +$45K 0.17% 96
2014
Q3 		$1.69M Sell
29,435
-1,099
-4% -$67.4K 0.19% 91
2014
Q2 		$2.04M Sell
30,534
-72
-0.2% -$4.87K 0.23% 77
2014
Q1 		$2.04M Sell
30,606
-1,679
-5% -$114K 0.24% 77
2013
Q4 		$2.15M Sell
32,285
-2,520
-7% -$163K 0.25% 68
2013
Q3 		$2.18M Sell
34,805
-219
-0.6% -$14.1K 0.28% 59
2013
Q2 		$2.19M Buy
+35,024
New +$2.22M 0.29% 57

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Gamble Jones Investment Counsel's GSK Position: Q4 2022 in Review

Gamble Jones Investment Counsel held its GSK (GSK) position steady in Q4 2022 at 10,693 shares worth $376K. The position accounts for 0.03% of the portfolio, ranked #159.

Gamble Jones Investment Counsel first reported a position in GSK in Q2 2013 and has held it in 39 quarters since. The position peaked at $2.19M in Q2 2013. 814 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

  • Gamble Jones Investment Counsel held 10,693 shares of GSK worth $376K as of Q4 2022.
  • Gamble Jones Investment Counsel left its GSK share count unchanged in Q4 2022.
  • GSK made up 0.03% of Gamble Jones Investment Counsel's portfolio in Q4 2022, its #159 holding.
  • Gamble Jones Investment Counsel first reported a position in GSK in Q2 2013 and has held it in 39 quarters since.
  • Gamble Jones Investment Counsel's GSK position peaked at $2.19M in Q2 2013.
  • 814 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Gamble Jones Investment Counsel's 13F filing for Q4 2022, filed 8 Feb 2023.